Prestige BioPharma Limited (KRX:950210)
South Korea
· Delayed Price · Currency is KRW 12,040
+910 (8.18%)
Last updated: Jun 27, 2025
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 142.67 billion as of June 27, 2025. Its market cap has increased by 48.93% in one year.
Market Cap
142.67B
Enterprise Value
176.18B
Revenue
8.66B
Ranking
n/a
PE Ratio
32.81
Stock Price
12,040.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 142.67B, a decrease of -60.43%. That is a compound annual growth rate of -20.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 142.67B | -21.44% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.46T |
| Celltrion | 35.49T |
| ALTEOGEN | 20.84T |
| Yuhan | 7,589.05B |
| SK Biopharmaceuticals | 7,236.14B |
| HLB Co., Ltd. | 6,512.41B |
| PharmaResearch | 4,992.23B |
| Peptron | 4,741.01B |